Brief report: updated efficacy and safety data from an integrated analysis of entrectinib in locally advanced/metastatic ROS1 fusion-positive non-small-cell lung cancer
Authors
Fan, Y.Drilon, A.
Chiu, C. H.
Loong, H. H. F.
Siena, S.
Krzakowski, M.
Dziadziuszko, R.
Zeuner, H.
Xue, C.
Krebs, Matthew G
Affiliation
Division of Cancer Sciences, The University of Manchester, and The Christie NHS Foundation TrustIssue Date
2023
Metadata
Show full item recordCitation
Fan Y, Drilon A, Chiu CH, Loong HHF, Siena S, Krzakowski M, et al. Brief Report: Updated Efficacy and Safety Data From an Integrated Analysis of Entrectinib in Locally Advanced/Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer. Clinical lung cancer. 2023 Dec 7. PubMed PMID: 38245456. Epub 2024/01/21.Journal
Clinical Lung CancerDOI
10.1016/j.cllc.2023.12.001PubMed ID
38245456Additional Links
https://dx.doi.org/10.1016/j.cllc.2023.12.001Type
Case ReportLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.cllc.2023.12.001
Scopus Count
Collections
Related articles
- Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.
- Authors: Drilon A, Siena S, Dziadziuszko R, Barlesi F, Krebs MG, Shaw AT, de Braud F, Rolfo C, Ahn MJ, Wolf J, Seto T, Cho BC, Patel MR, Chiu CH, John T, Goto K, Karapetis CS, Arkenau HT, Kim SW, Ohe Y, Li YC, Chae YK, Chung CH, Otterson GA, Murakami H, Lin CC, Tan DSW, Prenen H, Riehl T, Chow-Maneval E, Simmons B, Cui N, Johnson A, Eng S, Wilson TR, Doebele RC, trial investigators
- Issue date: 2020 Feb
- Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.
- Authors: Dziadziuszko R, Krebs MG, De Braud F, Siena S, Drilon A, Doebele RC, Patel MR, Cho BC, Liu SV, Ahn MJ, Chiu CH, Farago AF, Lin CC, Karapetis CS, Li YC, Day BM, Chen D, Wilson TR, Barlesi F
- Issue date: 2021 Apr 10
- Entrectinib for the treatment of metastatic NSCLC: safety and efficacy.
- Authors: Sartore-Bianchi A, Pizzutilo EG, Marrapese G, Tosi F, Cerea G, Siena S
- Issue date: 2020 May
- Entrectinib in ROS1-positive advanced non-small cell lung cancer: the phase 2/3 BFAST trial.
- Authors: Peters S, Gadgeel SM, Mok T, Nadal E, Kilickap S, Swalduz A, Cadranel J, Sugawara S, Chiu CH, Yu CJ, Moskovitz M, Tanaka T, Nersesian R, Shagan SM, Maclennan M, Mathisen M, Bhagawati-Prasad V, Diarra C, Assaf ZJ, Archer V, Dziadziuszko R
- Issue date: 2024 Jul
- Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer.
- Authors: Ku BM, Bae YH, Lee KY, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ
- Issue date: 2020 Apr